Acarix AB (publ) publishes Year-End Report 2022
Strategic shift towards full commercial focus on the US market now in place
As we sum up 2022, it becomes clear that Acarix has in a sh...
Acarix AB (publ) publicerar Bokslutskommuniké 2022
Strategiskt skifte till fullt kommersiellt fokus på USA-marknaden nu på plats
När vi summerar 2022 blir det tydligt att Acarix på kort ...
Acarix AB (publ) publishes Year-End Report 2022
Strategic shift towards full commercial focus on the US market now in placeAs we sum up 2022, it becomes clear that Acarix has in a sho...
Invitation to presentation of Acarix´s fourth quarter report
Acarix will publish its fourth quarter results on Thursday 16 February 2023 at 08.00 am (CEST). A live webcast will be held at 11.00 (C...
ACARIX förstärker USA:s kommersiella team
Acarix, en ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag anställningen av två nya medlemmar till Acarix kommersiel...
ACARIX strengthens US Commercial Team
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of two additional members of the Acarix ...
Acarix strengthens US Commercial Team
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of two additional members of the Acarix ...
Inbjudan till presentation av Acarix delårsrapport för fjärde kvartalet
Acarix publicerar sin rapport för fjärde kvartalet torsdagen den 16 februari 2023 kl 08.00. En direktsänd websändning kommer att hållas...
Invitation to presentation of Acarix´s fourth quarter report
Acarix will publish its fourth quarter results on Thursday 16 February 2023 at 08.00 am (CEST). A live webcast will be held at 11.00 (C...
Acarix deltar i 2023 BIO CEO & Investor Conference i New York City
Acarix, en ledare inom akustisk och AI-baserad hjärtdiagnostik, kommer för första gången att delta i den 25:e årliga BIO CEO & Inve...
Acarix is attending 2023 BIO CEO & Investor Conference in New York City
Acarix, a leader in innovative acoustic and AI-based cardiac diagnostics, will be attending for the first time the 25th annual BIO CEO ...
Acarix is attending 2023 BIO CEO & Investor Conference
Acarix, a leader in innovative acoustic and AI-based cardiac diagnostics, will be attending for the first time the 25th annual BIO CEO ...